← All organizations
Abecma
For profitWebsite ↗
Also known as: 2nd Department of Neurology, Faculty of MedicineCOMENIUS UNIVERSITY BRATISLAVA | 2seventy bio | 2seventy bio, Inc. | Comenius University | Comenius University and National Cancer Institute | Comenius University's Jessenius Faculty of Medicine | Faculty of Medicine Comenius University & Institute of Experimental Endocrinology SAS | University Hospital Bratislava, Comenius University, Bratislava,
Highest phase reached
Phase 2
First clinical trial
Jan 1, 2021Last known activity
Apr 4, 2025
Acquired by Bristol-Myers Squibb on Mar 11, 2025
Timeline
2020s
- Jan 1, 2021
Abecma— Founded
- Mar 11, 2025
Bristol-Myers Squibb— Acquired By
Drugs by trial phase (12 distinct, 12 trials)
Phase 2 (6 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Recent trials (14)
- NCT07024238CollaboratorN/AApr 4, 2025
- NCT06951581CollaboratorN/AJan 15, 2024
- NCT05939791Lead sponsorN/AApr 1, 2022
- NCT05169489Lead sponsorPhase 1/Phase 2Jan 24, 2022
- NCT05169489Study directorPhase 1/Phase 2Jan 24, 2022
- NCT05178225Lead sponsorN/AMay 1, 2021
- NCT03203096CollaboratorN/AJan 15, 2017
- NCT03330470Overall official - principal investigatorN/AJan 1, 2017
- NCT03330470CollaboratorN/AJan 1, 2017
- NCT03055559Overall official - principal investigatorN/AJun 1, 2016
- NCT03440125CollaboratorPhase 1/Phase 2Mar 15, 2016
- NCT02705209CollaboratorN/AOct 31, 2015
- NCT02011100Study directorN/ADec 1, 2013
- NCT02544685Overall official - principal investigatorPhase 2Jul 1, 2010
Details
- Founded
- Cambridge, MA, US Jan 1, 2021
- Last known activity
- Apr 4, 2025